Kamada Debt to Equity Ratio 2012-2018 | KMDA

Current and historical debt to equity ratio values for Kamada (KMDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Kamada debt/equity for the three months ending September 30, 2018 was 0.01.
Kamada Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.09B 0.01
2018-06-30 $0.00B $0.10B 0.01
2018-03-31 $0.00B $0.09B 0.01
2017-12-31 $0.00B $0.09B 0.02
2017-09-30 $0.00B $0.08B 0.02
2017-06-30 $0.00B $0.07B 0.02
2017-03-31 $0.00B $0.06B 0.02
2016-12-31 $0.00B $0.07B 0.02
2016-09-30 $0.00B $0.07B 0.02
2016-06-30 $0.00B $0.07B 0.02
2016-03-31 $0.00B $0.07B 0.01
2015-12-31 $0.00B $0.07B 0.00
2015-09-30 $0.00B $0.07B 0.00
2015-06-30 $0.00B $0.08B 0.00
2015-03-31 $0.00B $0.08B 0.00
2014-12-31 $0.00B $0.08B 0.00
2014-09-30 $0.01B $0.08B 0.10
2014-06-30 $0.01B $0.08B 0.10
2014-03-31 $0.01B $0.09B 0.09
2013-12-31 $0.01B $0.09B 0.08
2013-09-30 $0.02B $0.08B 0.25
2013-06-30 $0.02B $0.08B 0.25
2013-03-31 $0.02B $0.03B 0.73
2012-12-31 $0.02B $0.03B 0.66
2012-09-30 $0.02B $0.02B 0.93
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.195B $0.103B
Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.010B 14.13
Gilead Sciences (GILD) United States $87.604B 10.55
Biogen (BIIB) United States $64.432B 13.05
Celgene (CELG) United States $48.591B 9.43
Illumina (ILMN) United States $48.348B 56.32
Vertex Pharmaceuticals (VRTX) United States $44.270B 77.33
Regeneron Pharmaceuticals (REGN) United States $40.656B 20.60
Alexion Pharmaceuticals (ALXN) United States $25.618B 17.53
BioMarin Pharmaceutical (BMRN) United States $16.442B 0.00
Incyte (INCY) United States $13.960B 385.88
Seattle Genetics (SGEN) United States $9.759B 0.00
Exact Sciences (EXAS) United States $8.544B 0.00
Sarepta Therapeutics (SRPT) United States $8.353B 0.00
BeiGene (BGNE) Cayman Islands $8.129B 0.00
QIAGEN (QGEN) Netherlands $7.997B 25.58
Alnylam Pharmaceuticals (ALNY) United States $7.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.571B 48.41
Exelixis (EXEL) United States $6.273B 17.78
Bio-Techne Corp (TECH) United States $5.949B 40.19
Bluebird Bio (BLUE) United States $5.733B 0.00
Alkermes (ALKS) Ireland $5.356B 3447.00
Amarin (AMRN) Ireland $5.351B 0.00
Galapagos (GLPG) Belgium $5.260B 0.00
Guardant Health (GH) United States $3.751B 0.00
Immunomedics (IMMU) United States $3.590B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.546B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Array BioPharma (ARRY) United States $3.292B 0.00
Horizon Pharma Public (HZNP) Ireland $3.279B 13.49
ARGENX SE-ADR (ARGX) Netherlands $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.157B 0.00
Ligand Pharmaceuticals (LGND) United States $3.115B 23.83
Intercept Pharmaceuticals (ICPT) United States $3.102B 0.00
Akcea Therapeutics (AKCA) United States $2.861B 0.00
Repligen (RGEN) United States $2.713B 84.74
Ascendis Pharma (ASND) Denmark $2.613B 0.00
Allakos (ALLK) United States $2.590B 0.00
Genomic Health (GHDX) United States $2.586B 87.32
Blueprint Medicines (BPMC) United States $2.512B 0.00
China Biologic Products (CBPO) China $2.474B 17.61
ACADIA Pharmaceuticals (ACAD) United States $2.323B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.312B 0.00
Myriad Genetics (MYGN) United States $2.302B 22.81
Halozyme Therapeutics (HALO) United States $2.235B 49.87
Global Blood Therapeutics (GBT) United States $2.234B 0.00
Acceleron Pharma (XLRN) United States $2.212B 0.00
MyoKardia (MYOK) United States $2.194B 0.00
Arena Pharmaceuticals (ARNA) United States $2.024B 0.00
Amicus Therapeutics (FOLD) United States $1.999B 0.00
Denali Therapeutics (DNLI) United States $1.941B 0.00
Atara Biotherapeutics (ATRA) United States $1.934B 0.00
AnaptysBio (ANAB) United States $1.918B 0.00
REGENXBIO (RGNX) United States $1.915B 25.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.853B 0.00
Innoviva (INVA) United States $1.766B 9.99
Reata Pharmaceuticals (RETA) United States $1.763B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.529B 0.00
Cambrex (CBM) United States $1.484B 11.08
Rubius Therapeutics (RUBY) United States $1.483B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.476B 0.00
WAVE Life Sciences (WVE) Singapore $1.425B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.425B 113.17
Editas Medicine (EDIT) United States $1.415B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.364B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.332B 0.00
Mirati Therapeutics (MRTX) United States $1.309B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.308B 0.00
NeoGenomics (NEO) United States $1.290B 106.69
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
G1 THERAPEUTICS (GTHX) United States $1.233B 0.00
Lion Biotechnologies (IOVA) United States $1.222B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.206B 0.00
Insmed (INSM) United States $1.200B 0.00
Sangamo Therapeutics (SGMO) United States $1.199B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.169B 0.00
Clovis Oncology (CLVS) United States $1.132B 0.00
UniQure (QURE) Netherlands $1.071B 0.00
Fate Therapeutics (FATE) United States $1.056B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.022B 0.00
Apellis Pharmaceuticals (APLS) United States $1.009B 0.00
Retrophin (RTRX) United States $1.003B 0.00
Audentes Therapeutics (BOLD) United States $1.002B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.932B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.909B 0.00
Puma Biotechnology (PBYI) United States $0.897B 0.00
Novavax (NVAX) United States $0.854B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Solid Biosciences (SLDB) United States $0.840B 0.00
Cellectis (CLLS) France $0.835B 0.00
DBV Technologies (DBVT) France $0.821B 0.00
Athenex (ATNX) United States $0.817B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.806B 0.00
Revance Therapeutics (RVNC) United States $0.804B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.781B 0.00
Acorda Therapeutics (ACOR) United States $0.769B 9.73
Vericel (VCEL) United States $0.761B 0.00
AC Immune SA (ACIU) Switzerland $0.761B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.752B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.751B 0.00
Heska (HSKA) United States $0.740B 60.60
Aptinyx (APTX) United States $0.732B 0.00
Gritstone Oncology (GRTS) United States $0.731B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Principia Biopharma (PRNB) United States $0.701B 0.00
InflaRx (IFRX) Germany $0.688B 0.00
Dynavax Technologies (DVAX) United States $0.678B 0.00
Scholar Rock Holding (SRRK) United States $0.678B 0.00
Viking Therapeutics (VKTX) United States $0.677B 0.00
Coherus BioSciences (CHRS) United States $0.672B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.665B 0.00
CytomX Therapeutics (CTMX) United States $0.654B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.648B 0.00
ANI Pharmaceuticals (ANIP) United States $0.646B 12.36
UROGEN PHARMA (URGN) Israel $0.626B 0.00
UNITY Biotechnology (UBX) $0.621B 0.00
Cara Therapeutics (CARA) United States $0.617B 0.00
TWIST BIOSCIENC (TWST) United States $0.612B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.609B 0.00
AVROBIO (AVRO) United States $0.589B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.548B 0.00
Arvinas (ARVN) United States $0.544B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.543B 0.00
Arcus Biosciences (RCUS) United States $0.540B 0.00
ObsEva SA (OBSV) Switzerland $0.534B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Eidos Therapeutics (EIDX) United States $0.521B 0.00
RA PHARMCTL INC (RARX) United States $0.515B 0.00
Kezar Life Sciences (KZR) United States $0.513B 0.00
Epizyme (EPZM) United States $0.512B 0.00
Inovio Pharmaceuticals (INO) United States $0.495B 0.00
Osiris Therapeutics (OSIR) United States $0.486B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Prothena (PRTA) Ireland $0.464B 0.00
Zymeworks (ZYME) Canada $0.462B 0.00
Senesco Technologies (ELOX) United States $0.459B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.453B 0.00
Anika Therapeutics (ANIK) United States $0.445B 18.42
Replimune (REPL) United States $0.440B 0.00
PDL BioPharma (PDLI) United States $0.436B 7.12
Cytokineticsorporated (CYTK) United States $0.436B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.423B 0.00
Kindred Biosciences (KIN) United States $0.420B 0.00
Sinovac Biotech (SVA) China $0.405B 0.00
Zealand Pharma (ZEAL) Denmark $0.392B 4.32
Mesoblast (MESO) Australia $0.388B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.385B 0.00
Abeona Therapeutics (ABEO) United States $0.382B 0.00
Cellular Biomedicine (CBMG) United States $0.373B 0.00
MediciNova (MNOV) United States $0.369B 0.00
ResTORbio (TORC) United States $0.354B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.351B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.345B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
Stemline Therapeutics (STML) United States $0.338B 0.00
Krystal Biotech (KRYS) United States $0.336B 0.00
MeiraGTx Holdings (MGTX) United States $0.331B 0.00
Sorrento Therapeutics (SRNE) United States $0.326B 53.40
Verastem (VSTM) United States $0.322B 0.00
Kodiak Sciences (KOD) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Agenus (AGEN) United States $0.314B 0.00
LogicBio Therapeutics (LOGC) United States $0.310B 0.00
Albireo Pharma (ALBO) United States $0.306B 0.00
Athersys (ATHX) United States $0.295B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.285B 0.00
Seres Therapeutics (MCRB) United States $0.283B 0.00
MannKind (MNKD) United States $0.278B 0.00
Syros Pharmaceuticals (SYRS) United States $0.277B 0.00
Magenta Therapeutics (MGTA) United States $0.276B 0.00
Merus (MRUS) Netherlands $0.274B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.264B 0.00
Geron (GERN) United States $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.257B 0.00
TOCAGEN INC (TOCA) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.254B 0.00
BioDelivery Sciences (BDSI) United States $0.250B 0.00
Equillium (EQ) United States $0.250B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Intec Pharma (NTEC) Israel $0.246B 0.00
Celcuity (CELC) United States $0.234B 0.00
Adverum Biotechnologies (ADVM) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Celyad SA (CYAD) Belgium $0.227B 0.00
Aduro Biotech (ADRO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Strongbridge Biopharma (SBBP) United States $0.213B 0.00
PSivida (EYPT) United States $0.208B 0.00
Urovant Sciences (UROV) United States $0.195B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.193B 0.00
Synlogic (SYBX) United States $0.187B 0.00
Idera Pharmaceuticals (IDRA) United States $0.184B 0.00
Proteostasis Therapeutics (PTI) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.180B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.178B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Unum Therapeutics (UMRX) United States $0.172B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
BioTime (BTX) United States $0.163B 0.00
Protagonist Therapeutics (PTGX) United States $0.162B 0.00
Compugen (CGEN) Israel $0.162B 0.00
XBiotech (XBIT) United States $0.155B 0.00
Palatin Technologies (PTN) United States $0.154B 19.00
ChromaDex (CDXC) United States $0.154B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.154B 0.00
Axovant Sciences (AXON) United Kingdom $0.152B 0.00
Cohbar (CWBR) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.139B 0.00
Cerecor (CERC) United States $0.137B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.136B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.126B 0.00
Mersana Therapeutics (MRSN) United States $0.124B 0.00
Selecta Biosciences (SELB) United States $0.122B 0.00
XOMA (XOMA) United States $0.122B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Pfenex (PFNX) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Eleven Biotherapeutics (SESN) United States $0.118B 0.00
Spero Therapeutics (SPRO) United States $0.118B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
NantKwest (NK) United States $0.116B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Pluristem Therapeutics (PSTI) Israel $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.105B 117.33
Sienna Biopharmaceuticals (SNNA) United States $0.104B 0.00
ETON PHARMACEUT (ETON) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.103B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Cue Biopharma (CUE) United States $0.097B 0.00
Motif Bio Plc (MTFB) United States $0.097B 0.00
Anavex Life Sciences (AVXL) United States $0.096B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.096B 0.00
Signal Genetics (MGEN) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.095B 0.00
Neothetics (EVFM) United States $0.092B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Cel-Sci (CVM) United States $0.091B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Mustang Bio (MBIO) United States $0.087B 0.00
Provention Bio (PRVB) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
OVID THERAPEUTC (OVID) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.075B 0.00
VolitionRX (VNRX) Singapore $0.073B 0.00
ITUS (ANIX) United States $0.073B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
Ophthotech (OPHT) United States $0.061B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Evogene (EVGN) Israel $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Alcobra (ARCT) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.054B 10.31
Versartis (ARAV) United States $0.054B 4.73
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
Arsanis (ASNS) United States $0.051B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Aptevo Therapeutics (APVO) United States $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Oncobiologics (OTLK) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.037B 5.94
Celsion (CLSN) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
TRACON Pharmaceuticals (TCON) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Oragenics (OGEN) United States $0.031B 0.00
GTx (GTXI) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Histogenics (HSGX) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
CytRx (CYTR) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 8.70
ATyr Pharma (LIFE) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00